研究目的
To determine whether blue light-emitting diode phototherapy (BLP) in preterm infants induces oxidative DNA damage as indicated by 8-hydroxy-2′deoxyguanosine (8-OHdG).
研究成果
BLP at irradiances up to 35 μW/cm2/nm given to preterm infants ≤32 weeks’ gestation does not affect 8-OHdG, an oxidative marker of DNA damage. The study suggests that BLP does not induce oxidative DNA damage in preterm infants, addressing concerns about the safety of phototherapy in this vulnerable population.
研究不足
The study did not include a negative control group that received no phototherapy at all. No infants received irradiances higher than 35 μW/cm2/nm, and the relatively small sample size did not allow assessment of the influence of all potential confounders.
1:Experimental Design and Method Selection:
Observational cohort study design to assess the effects of BLP on oxidative DNA damage in preterm infants.
2:Sample Selection and Data Sources:
40 preterm infants (24–32 weeks’ gestational age) were enrolled, and 481 urine samples were collected during the first week after birth.
3:List of Experimental Equipment and Materials:
Phototherapy was administered using neoBLUE mini or Mavi LED Phototherapy System. Urine samples were collected using PeeSpots.
4:Experimental Procedures and Operational Workflow:
Urine samples were analyzed for 8-OHdG and creatinine to calculate the 8-OHdG/creatinine ratio. Phototherapy duration and irradiance levels were monitored.
5:Data Analysis Methods:
Generalized estimating equations (GEEs) were used to analyze changes in 8-OHdG/creatinine ratios over time, correcting for postnatal age.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容